Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-11 Sale | 2024-03-11 5:20 pm | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 14,235 | $0.8818 | $12,552 | 234,301 (Direct) | View |
| 2024-02-12 Sale | 2024-02-12 5:23 pm | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 787 | $1.0072 | $793 | 248,536 (Direct) | View |
| 2023-11-01 Sale | 2023-11-03 4:39 pm | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 67,695 | $0.73 | $49,417 | 249,323 (Direct) | View |
| 2023-03-10 Sale | 2023-03-13 4:48 pm | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 16,806 | $0.84 | $14,117 | 86,373 (Direct) | View |
| 2023-02-13 Sale | 2023-02-15 5:13 pm | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 928 | $0.93 | $863 | 103,179 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-13 Option Award | 2024-02-16 5:08 pm | N/A 2034-02-13 | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 428,248 | $0 | 428,248 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-02 4:59 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 230,645 | $0 | 317,018 (Direct) | View |
| 2022-11-07 Option Award | 2022-11-09 4:22 pm | N/A 2032-11-07 | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-01 4:09 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 97,000 | $0 | 104,107 (Direct) | View |
| 2022-02-11 Tax Withholding | 2022-02-14 4:21 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 928 | $0 | 7,107 (Direct) | View |
| 2021-03-24 Option Award | 2021-03-25 5:07 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 8,035 | $0 | 8,035 (Direct) | View |
| 2020-11-30 Option Award | 2020-12-01 5:28 pm | N/A 2030-11-29 | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 121,150 | $6.6 | 121,150 (Direct) | View |